Home Drug maker Transcept rejects Shkreli play to boost ownership stake
 

Keywords :   


Drug maker Transcept rejects Shkreli play to boost ownership stake

2013-10-01 04:47:27| Biotech - Topix.net

Transcept Pharmaceuticals Inc. rejected a request from Retrophin Inc. to triple its ownership stake in the Richmond drug developer from 4.9 percent to up to 15 percent.

Tags: play drug ownership maker

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »